List view / Grid view
Filter the results
The circuit of life: saving on manufacturing, waste and delivery-related supply chain inefficiencies
Many pharmaceutical companies have complicated supply chains that are inefficient and ill-equipped to deal with current demands. This article explores how digitalising the healthcare supply chain can address the pharmaceutical sector's increasing financial-, capacity- and waste-related strains associated with our ageing population and the soaring costs of new treatments.
A simple, sensitive and selective direct method using IC coupled to a single quadrupole MS to analyse organic acids in drug solutions.
Separate your science from the status quo, advanced solutions offering superior retention time stability, flexible integration and minimal maintenance.
Stability testing is a vital part of product development and is conducted throughout a product’s life cycle.
Phoebe Chubb explores research that suggests laboratory productivity could be improved by 30 to 40 percent with digitalisation and IoT implementation.
Maurits Lugard, Josefine Sommer and Antoine Robin from Sidley Austin dissect the recently released EU guidance to accompany the MDR, on what a significant change is and how to collect clinical evidence for medical device software.
The pharmaceutical industry is set to greatly benefit from the use of artificial intelligence (AI), due to its wide range of applications. Sydney Tierney discusses how machine learning can enhance marketing, manufacturing and drug trials.
Ranitidine tablets have been recalled due to the possibility of the products containing unacceptable levels of NDMA.
A new report has predicted that, even though the healthcare sector has been slow on the uptake, blockchain will play a pivotal role, creating new ways for pharmaceutical stakeholders to exchange information.
Ten priority actions have been recommended for the European medicines regulatory network to evolve its approach to data use.